BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Provenzano M, Andreucci M, De Nicola L, Garofalo C, Battaglia Y, Borrelli S, Gagliardi I, Faga T, Michael A, Mastroroberto P, Serraino GF, Licastro N, Ielapi N, Serra R. The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients. Biomed Res Int 2020;2020:2314128. [PMID: 33102575 DOI: 10.1155/2020/2314128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chou P, Wu P, Wu P, Huang T, Huang J, Chen S, Lee S, Kuo M, Chiu Y, Hsu Y, Chang J, Hwang S. Investigation of the Relationship between Cardiovascular Biomarkers and Brachial–Ankle Pulse Wave Velocity in Hemodialysis Patients. JPM 2022;12:636. [DOI: 10.3390/jpm12040636] [Reference Citation Analysis]
2 Shah W, Aleem M, Iqbal MA, Islam MA, Ahmed U, Srivastava G, Lin JC. A Machine-Learning-Based System for Prediction of Cardiovascular and Chronic Respiratory Diseases. J Healthc Eng 2021;2021:2621655. [PMID: 34760140 DOI: 10.1155/2021/2621655] [Reference Citation Analysis]
3 Serra R, Bracale UM, Ielapi N, Del Guercio L, Di Taranto MD, Sodo M, Michael A, Faga T, Bevacqua E, Jiritano F, Serraino GF, Mastroroberto P, Provenzano M, Andreucci M. The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization. Int J Gen Med 2021;14:3749-59. [PMID: 34326661 DOI: 10.2147/IJGM.S322417] [Reference Citation Analysis]
4 Lin PC, Chou CL, Ou SH, Fang TC, Chen JS. Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach. Nutrients 2021;13:469. [PMID: 33573242 DOI: 10.3390/nu13020469] [Reference Citation Analysis]
5 Cupisti A, Giannese D, Moriconi D, D'Alessandro C, Torreggiani M, Piccoli GB. Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets? Front Med (Lausanne) 2020;7:622593. [PMID: 33425967 DOI: 10.3389/fmed.2020.622593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Shabaka A, Cases-Corona C, Fernandez-Juarez G. Therapeutic Insights in Chronic Kidney Disease Progression. Front Med (Lausanne) 2021;8:645187. [PMID: 33708784 DOI: 10.3389/fmed.2021.645187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Provenzano M, Serra R, Michael A, Bolignano D, Coppolino G, Ielapi N, Serraino GF, Mastroroberto P, Locatelli F, De Nicola L, Andreucci M. Smoking habit as a risk amplifier in chronic kidney disease patients. Sci Rep 2021;11:14778. [PMID: 34285279 DOI: 10.1038/s41598-021-94270-w] [Reference Citation Analysis]
8 Andreucci M, Provenzano M, Faga T, Michael A, Patella G, Mastroroberto P, Serraino GF, Bracale UM, Ielapi N, Serra R. Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases. Biomolecules 2021;11:194. [PMID: 33573220 DOI: 10.3390/biom11020194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Provenzano M, Andreucci M, Garofalo C, Minutolo R, Serra R, De Nicola L. Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease. Expert Opin Investig Drugs 2021;30:253-62. [PMID: 33356648 DOI: 10.1080/13543784.2021.1869720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Sarafidis P, Martens S, Saratzis A, Kadian-Dodov D, Murray PT, Shanahan CM, Hamdan AD, Engelman DT, Teichgräber U, Herzog CA, Cheung M, Jadoul M, Winkelmayer WC, Reinecke H, Johansen K; for Conference Participants. Diseases of the Aorta and Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Cardiovasc Res 2021:cvab287. [PMID: 34469520 DOI: 10.1093/cvr/cvab287] [Reference Citation Analysis]
11 Crugliano G, Serra R, Ielapi N, Battaglia Y, Coppolino G, Bolignano D, Bracale UM, Pisani A, Faga T, Michael A, Provenzano M, Andreucci M. Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: "Can the Promise Be Kept?". Int J Mol Sci 2021;22:12590. [PMID: 34830468 DOI: 10.3390/ijms222212590] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]